Zurich Cantonal Bank’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Zurich Cantonal Bank’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,409	Closed	-$95.8K	–	2917
2022 Q4	$95.8K	Buy	+6,409	New	+$88.7K	﹤0.01%	2298

Zurich Cantonal Bank's AVEO Position: Q1 2023 in Review

Zurich Cantonal Bank sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 6,409 shares — an estimated $95.8K sold.

Zurich Cantonal Bank first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $95.8K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Zurich Cantonal Bank reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 6,409 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $95.8K.
Zurich Cantonal Bank first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Zurich Cantonal Bank's AVEO Pharmaceuticals, Inc. position peaked at $95.8K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Zurich Cantonal Bank's 13F filing for Q1 2023, filed 8 May 2023.